A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC)
Publication
, Conference
Czito, B; Willett, C; Palta, M; Kennedy-Newton, P; Uronis, H
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2012
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2012
Volume
84
Issue
3
Start / End Page
S42 / S42
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Czito, B., Willett, C., Palta, M., Kennedy-Newton, P., & Uronis, H. (2012). A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC). In International Journal of Radiation Oncology*Biology*Physics (Vol. 84, pp. S42–S42). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2012.07.321
Czito, B., C. Willett, M. Palta, P. Kennedy-Newton, and H. Uronis. “A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC).” In International Journal of Radiation Oncology*Biology*Physics, 84:S42–S42. Elsevier BV, 2012. https://doi.org/10.1016/j.ijrobp.2012.07.321.
Czito B, Willett C, Palta M, Kennedy-Newton P, Uronis H. A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC). In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S42–S42.
Czito, B., et al. “A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC).” International Journal of Radiation Oncology*Biology*Physics, vol. 84, no. 3, Elsevier BV, 2012, pp. S42–S42. Crossref, doi:10.1016/j.ijrobp.2012.07.321.
Czito B, Willett C, Palta M, Kennedy-Newton P, Uronis H. A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab), and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC). International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S42–S42.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
November 2012
Volume
84
Issue
3
Start / End Page
S42 / S42
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences